The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia
about
MIF: Implications in the Pathoetiology of Systemic Lupus ErythematosusHost innate immune responses to sepsisRole of macrophage migration inhibitory factor in age-related lung diseaseMacrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to Mycobacterium tuberculosis.Expression and function of macrophage migration inhibitory factor (MIF) in melioidosis.Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus.Blood levels of macrophage migration inhibitory factor after successful resuscitation from cardiac arrest.Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis.Association of macrophage migration inhibitory factor (MIF) polymorphisms with risk of meningitis from Streptococcus pneumoniae.Dual effect of a polymorphism in the macrophage migration inhibitory factor gene is associated with new-onset Graves disease in a Taiwanese Chinese population.Dual effect of the macrophage migration inhibitory factor gene on the development and severity of human systemic lupus erythematosus.A genetic study of steroid-resistant nephrotic syndrome: relationship between polymorphism -173 G to C in the MIF gene and serum level MIF in children.High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ dysfunction in patients after cardiac surgeryInteraction of MIF Family Proteins in Myocardial Ischemia/Reperfusion Damage and Their Influence on Clinical Outcome of Cardiac Surgery PatientsMacrophage Migration Inhibitory Factor Is Detrimental in Pneumococcal Pneumonia and a Target for Therapeutic ImmunomodulationFunctional polymorphisms of macrophage migration inhibitory factor as predictors of morbidity and mortality of pneumococcal meningitis.Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.Cytokines in sepsis: potent immunoregulators and potential therapeutic targets--an updated view.Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulationThe role of macrophage migration inhibitory factor in autoimmune liver disease.A MIF haplotype is associated with the outcome of patients with severe sepsis: a case control study.Functional polymorphisms in the gene encoding macrophage migration inhibitory factor are associated with Gram-negative bacteremia in older adultsPlasma Levels of Macrophage Migration Inhibitory Factor and d-Dopachrome Tautomerase Show a Highly Specific Profile in Early Life.Update in community-acquired and nosocomial pneumonia 2009.Genetic risk of acute pulmonary infections and sepsis.Can immunogenetics illuminate the diverse manifestations of respiratory infections?Genetic predisposition to respiratory infection and sepsis.D-dopachrome tautomerase (D-DT or MIF-2): doubling the MIF cytokine family.MIF, MIF alleles, and prospects for therapeutic intervention in autoimmunity.The beginning of personalized medicine in sepsis: small steps to a bright future.Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings.The increased concentration of macrophage migration inhibitory factor in serum and cerebrospinal fluid of patients with tick-borne encephalitisPharmacogenomics and pharmacogenetics for the intensive care unit: a narrative review.Macrophage migration inhibitory factor promotes clearance of pneumococcal colonizationMacrophage migration inhibitory factor deficiency is associated with impaired killing of gram-negative bacteria by macrophages and increased susceptibility to Klebsiella pneumoniae sepsis.MIF family cytokines in cardiovascular diseases and prospects for precision-based therapeutics.Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis.MIF and D-DT are potential disease severity modifiers in male MS subjects.Graph Theoretical Analysis of Genome-Scale Data: Examination of Gene Activation Occurring in the Setting of Community-Acquired Pneumonia.Serum Macrophage Migration Inhibitory Factor as a Biomarker of Active Pulmonary Tuberculosis.
P2860
Q26776111-7C8A7430-A43A-43B8-89C9-8FEF5C9F2224Q26864635-29C8BE23-F054-4224-80F9-B5F7C6C83476Q28081711-DBEEDC6F-7EE6-4D30-9737-9A3A08C67CEBQ30414897-A5486B38-30B3-4C65-BA35-9B3B4EE32B5CQ33532590-1EA2B38B-5864-42ED-B012-8E96E20D77B8Q33598493-94957011-604E-4047-8708-B4FCEF16E5F6Q34233529-88E72D6D-5776-4FE0-9599-431760BA9893Q34414970-FDBBDDD6-6808-437A-BAB8-AFE0ED42272FQ34553426-65C90FA4-5E4C-424F-AF40-393029BC7FD4Q35131251-488A14B8-DC55-440C-ACFE-AE80A918C24EQ35585133-762C0EE1-730E-4364-8D4C-F6D73BCB72FDQ35833793-B3AF7B8F-D2BD-4031-9BC6-265B9CE03A23Q36130973-2FA9FD9B-D5B9-46E4-BB6A-21C0AF0CCE93Q36191684-1CCFB7D0-D6B9-4BEF-9E58-C0627E3A692AQ36208600-11E09B83-94CF-4017-8605-729593635C59Q36770589-F2F725EB-8976-4223-8918-2C0868BA4AC1Q36848077-208DB0D1-5EAA-4B04-A7E7-ED4738B07845Q36990515-112E3418-803F-4AA3-BDD4-F6A69BA0EF87Q37297899-174349B9-2AA8-4AAE-BB82-D65BE430E1C5Q37423459-7DA7CDB8-AC3F-4FBF-844C-EA5D9ED13DAFQ37463053-FF10876D-47B5-498F-A1FA-0746E61476CAQ37582334-EC58B871-12D1-4127-A566-536CDE7E05AFQ37604131-846EF8B9-2232-4450-8ED3-178D0209B2BBQ37728782-DB37AB69-561E-4F23-B10E-F6469E841366Q37734450-545501AE-9352-426B-BB38-78943CCCBC90Q37763373-018BCAAB-4DED-49B8-BA11-368D11372589Q37970138-6411867C-779F-42F5-85B5-EAA594AB15B1Q38002982-C62908BD-CE29-45D9-9D97-C21CBEEF9156Q38042574-63D6429D-8520-456E-843E-5366AE8C29B7Q38191987-83DFBD68-E449-474A-8878-7AC0364C67CCQ38201763-653102E9-FDF3-4B9B-957F-5D0BC373BE6FQ38710834-ECB594C6-6BBA-4E86-99C5-64FD9BB6EAFEQ38983589-12E0D3BE-BC9A-4DFA-98C1-CCCEB1FE3847Q38984814-2F4937DF-3B56-4CD1-81DB-C47B230F0D73Q39249552-D19E31B9-D439-478D-8B94-AFECA18DCE72Q39340752-FE083956-2AD7-4B9B-BBCA-9AD883B309CEQ40350248-73BB9F59-6A93-4C35-B0B0-47FCA52105E2Q46234913-3E4DF150-31D6-4509-B557-888C122A6EBFQ47429841-10E1E4BD-8013-495A-B18A-C091303F0578Q47731806-F5A3FE80-867D-4245-A085-E04B08E9EAA8
P2860
The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The influence of macrophage mi ...... m community-acquired pneumonia
@en
The influence of macrophage mi ...... community-acquired pneumonia.
@nl
type
label
The influence of macrophage mi ...... m community-acquired pneumonia
@en
The influence of macrophage mi ...... community-acquired pneumonia.
@nl
prefLabel
The influence of macrophage mi ...... m community-acquired pneumonia
@en
The influence of macrophage mi ...... community-acquired pneumonia.
@nl
P2093
P2860
P356
P1433
P1476
The influence of macrophage mi ...... m community-acquired pneumonia
@en
P2093
David Finegold
John A Kellum
Lisa Weissfeld
Melinda Carter
Richard Bucala
Robert Ferrell
Sachin Yende
Zhi-Yong Peng
P2860
P304
P356
10.1096/FJ.09-129445
P407
P577
2009-04-03T00:00:00Z